Reducing Late-Stage Biologic Failure with Immune Assays- An Interview with Harald Kropshofer

Summary: There have been some high profile cases of antibodies causing severe reactions, as well as posing a high risk to patients, these late stage failures are hugely costly. Is there a way to prevent or predict these immune reactions to biologics? We spoke to Harald Kropshofer Senior